Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr;4(4):853-9.
doi: 10.2215/CJN.05471008. Epub 2009 Apr 1.

Hyperglycemia during the immediate period after kidney transplantation

Harini A Chakkera  1 , E Jennifer Weil, Janna Castro, Raymond L Heilman, Kunam S Reddy, Marek J Mazur, Khaled Hamawi, David C Mulligan, Adyr A Moss, Kristin L Mekeel, Fernando G Cosio, Curtiss B Cook
Affiliations

Hyperglycemia during the immediate period after kidney transplantation

Harini A Chakkera et al. Clin J Am Soc Nephrol. 2009 Apr.

Abstract

Background and objectives: Hyperglycemia and new-onset diabetes occurs frequently after kidney transplantation. The stress of surgery and exposure to immunosuppression medications have metabolic effects and can cause or worsen preexisting hyperglycemia. To our knowledge, hyperglycemia in the immediate posttransplantation period has not been studied.

Design, setting, participants, & measurements: We conducted a retrospective, observational study to characterize the prevalence and assess the pharmacologic management of hyperglycemia in kidney transplant recipients who underwent transplantation at our center between June 1999 and December 2006. Data were abstracted from electronic and pharmacy databases.

Results: The study cohort included 424 patients (mean age 51 yr; 58% men; 25% with pretransplantation diabetes). All patients with and 87% without pretransplantation diabetes had evidence of hyperglycemia (bedside glucose >or=200 mg/dl or physician-instituted insulin therapy), whereas the prevalence of hypoglycemia was low (4.5%). Hyperglycemia was sustained throughout hospitalization. All patients with and 66% without pretransplantation diabetes required insulin at hospital discharge. Patients with pretransplantation diabetes were treated primarily with short-acting insulin during the first 24 h after transplantation but were transitioned to long-acting insulin as the hospital stay progressed.

Conclusions: Investigators have historically attempted to identify hyperglycemia after hospital discharge. Our data indicate that a substantial number of patients without pretransplantation diabetes develop hyperglycemia and require insulin during the hospital phase of their care immediately after kidney transplantation. Prospective studies are needed to delineate factors that contribute to development of new-onset diabetes after transplantation among patients with transient hyperglycemia.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A and B) Inpatient hyperglycemia prevalence after kidney transplantation in patients with and without pretransplantation diabetes (A; *P < 0.001) and in the subset of patients with known diabetes according to outpatient pretransplantation insulin use (B; *P < 0.05). Hyperglycemia was defined as blood sugar >200 mg/dl or physician-ordered administration of insulin therapy.
Figure 2.
Figure 2.
(A and B) Pattern of inpatient insulin administration after kidney transplantation in patients with and without pretransplantation diabetes (A) and in the subset of patients with known diabetes according to outpatient pretransplantation insulin use (B).
See this image and copyright information in PMC

References

    1. Baid S, Cosimi AB, Farrell ML, Schoenfeld DA, Feng S, Chung RT, Tolkoff-Rubin N, Pascual M: Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 72: 1066–1072, 2001 - PubMed
    1. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernandez D, Kasiske BL, Kiberd B, Krentz A, Legendre C, Marchetti P, Markell M, van der Woude FJ, Wheeler DC: New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75: SS3–SS24, 2003 - PubMed
    1. Hur KY, Kim MS, Kim YS, Kang ES, Nam JH, Kim SH, Nam CM, Ahn CW, Cha BS, Kim SI, Lee HC: Risk factors associated with the onset and progression of posttransplantation diabetes in renal allograft recipients. Diabetes Care 30: 609–615, 2007 - PubMed
    1. John PR, Thuluvath PJ: Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 8: 708–713, 2002 - PubMed
    1. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3: 178–185, 2003 - PubMed

Publication types

MeSH terms